Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-012357
Filing Date
2021-05-20
Accepted
2021-05-20 16:24:03
Documents
1
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5908
  Complete submission text file 0001493152-21-012357.txt   7508
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Issuer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7389 Services-Business Services, NEC

Mailing Address PO BOX 3094 REDWOOD CITY CA 94064
Business Address
Arrow Alexander K. (Reporting) CIK: 0001497166 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12555 | Film No.: 21944814